Class Notes (839,147)
Canada (511,218)
Psychology (7,818)
PSYB65H3 (519)
Forget (11)
Lecture 6

Lecture 6.doc

3 Pages
82 Views

Department
Psychology
Course Code
PSYB65H3
Professor
Forget

This preview shows page 1. Sign up to view the full 3 pages of the document.
Description
Lecture 6 - Psychiatric Disorders Schizophrenia - most patients have auditory hallucinations – ppl talking to them, and delusions – ppl plotting against them - recent findings show that sch and affective (emotional) disorder like depression share the same genes - age of onset prior to 30, usually early adulthood Neuropsychological: - poor performance in frontal lobe tasks; tests of frontal lobe function => issues in the frontal lobes, studies aren’t 100% conclusive - poor performance on tests of verbal and nonverbal memory - most other neuropsych tests show completely normal - most patients have enlarged ventricles and lighter brains => may be due to the prescribed tranquilizers that patients have to take for many years - hard to determine what effects are caused by the actual disease, and what effects are caused due to side effects of the medication Genetic: - 1% of population develops sch, in immediate family 10-15% will develop if a relative has it (parents, children, siblings) => suggests genetic basis - twin studies show di-zygotic (non-identical) ratio is about 10-15% (same as other family members); monozygotic (identical) prevalence goes up 40-75% => something else at play, since identical twins have identical DNA, should be 100% prevalence => other factors alter the prevalence - twins separated at birth 9 out of 12 cases had sch in both twins => predominantly genetic Psychopharmacology: - early work done w anti-histamines – makes ppl drowsy => tried w sch patients – first pharmacological tool, in order to attempt to calm patients down - it was found that drugs that were most effective were all dopamine antagonists => most used were phenothiazines, most common being chlorpromazine (most effective) => block biogenic amines/monoamines receptor site, effectiveness of the drug were selective dopamine antagonists – blocking the dopamine receptor - stimulating dopaminergic system, eg by using amphetamine (ecstasy) resulted in sch symptoms reappearing - ppl who take amphetamines in high doses over long time show sch symptoms (psychiatrists cant tell them from real sch patients) => have hallucinations and delusions *blocking receptors makes ppl better, stimulating receptors makes ppl worse/makes normal ppl appear like sch - brain tissue showed normal dopamine levels, but # of dopamine receptors (D4 receptor) is 6 times more abundant => certain ppl born w more dopamine receptors - need to be careful w blocking too many receptors => too little dopamine can result in Parkinson’s symptoms - continuum between Parkinson’s and Schizophrenia Affective Disorders 1. Depression: => used chemicals to reduce blood pressure, eg rhezorpine – causes reduction in monoamines (leak from synaptic vesicles) => patients taking the drug got an induced depression – monoamines related to depression 1 - aldomet which lowers bp blocks the synthesis of norepinephrine => also causes depression => led to basis for depression as a neurological disorder - not situational/environmental - brains of depressed patients (suicidal victims) were used to measure levels of monoamines => 20-25% had a reduction in 5HIAA (metabolite – byproduct of serotonin) - serotonin itself was reduced in depressed patients - treatments was tried by increasing levels of biogenic amines => most effective were tricyclic antidepressants – block serotonin and norepinephrine re-uptake resulting in increased activity due to them remaining in the synaptic cleft => very little effect on dopamine – dopamine not involved in depression - tried increasing serotonin by increasing the precursor (tryptophan) – very effective at treating depression Monoamine oxidases: enzymes that break down the transmitters that aren’t packaged effectively Monoamine oxidase inhibitors: inhibit monoamine oxidase activity, allows for monoamine availability; increased monoamines resulted
More Less
Unlock Document

Only page 1 are available for preview. Some parts have been intentionally blurred.

Unlock Document
You're Reading a Preview

Unlock to view full version

Unlock Document

Log In


OR

Join OneClass

Access over 10 million pages of study
documents for 1.3 million courses.

Sign up

Join to view


OR

By registering, I agree to the Terms and Privacy Policies
Already have an account?
Just a few more details

So we can recommend you notes for your school.

Reset Password

Please enter below the email address you registered with and we will send you a link to reset your password.

Add your courses

Get notes from the top students in your class.


Submit